Ling Yu
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes 7
- Renal Diseases and Glomerulopathies 6
- Parathyroid Disorders and Treatments 5
- Dialysis and Renal Disease Management 5
-
- Renin-Angiotensin System Studies 5
- Obstetrics and Gynecology top 10%
-
- Cerebrovascular and Carotid Artery Diseases 6
-
- Pharmacological Effects of Natural Compounds 4
-
- Neurological Disease Mechanisms and Treatments 4
Ling Yu
53 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Nephrology 404
- Cardiology and Cardiovascular Medicine 420
- Endocrinology, Diabetes and Metabolism 304
- Cancer Research 142
- Obstetrics and Gynecology 66
Countries citing papers authored by Ling Yu
This map shows the geographic impact of Ling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Yu more than expected).
Fields of papers citing papers by Ling Yu
This network shows the impact of papers produced by Ling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Yu. The network helps show where Ling Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 15 | |
| 4 | 2020 | 25 | |
| 5 | 2019 | 10 | |
| 6 | 2019 | 12 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 24 | |
| 9 | 2017 | 1 | |
| 10 | 2016 | 34 | |
| 11 | 2016 | 10 | |
| 12 | 2015 | 8 | |
| 13 | Clinical study of sinomenine combined with methotrexate on the repair of bone destruction in rheumatoid arthritis | 2014 | 2 |
| 14 | 2014 | 25 | |
| 15 | 2014 | 26 | |
| 16 | 2013 | 38 | |
| 17 | 2003 | 115 | |
| 18 | 2003 | 151 | |
| 19 | 2003 | 51 | |
| 20 | 1999 | 23 |
About Ling Yu
Ling Yu is a scholar working on Nephrology, Pharmacology and Neurology, having authored 54 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (6 papers), Cerebrovascular and Carotid Artery Diseases (6 papers), Parathyroid Disorders and Treatments (5 papers), Dialysis and Renal Disease Management (5 papers), Renin-Angiotensin System Studies (5 papers), Pharmacological Effects of Natural Compounds (4 papers) and Neurological Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Nephrology (404 citations), Cardiology and Cardiovascular Medicine (420 citations) and Endocrinology, Diabetes and Metabolism (304 citations). Ling Yu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yufeng Huang, Wayne A. Border, Nancy A. Noble, Daniel A. Lawrence, David J. McQuillan, Masashi Haraguchi, Yiling Ding, Han Li, Shixiang Wang and Qun Xu. Their work appears in journals such as Kidney & Blood Pressure Research, Kidney International, Blood Purification, Journal of Clinical Investigation and Hypertension Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.